{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:26:42Z","timestamp":1787344002642,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Approximately 20% of all cancers contain mutations in genes coding for components of the SWI\/SNF chromatin remodeling complex, which exists in three main subtypes: cBAF, PBAF, and GBAF. Mutations in SWI\/SNF genes may disrupt chromatin remodeling and deregulate epigenetic processes, leading to aberrant gene expression profiles. However, the gene expression profiles of SWI\/SNF genes and subtypes across different tumor types in relation to SWI\/SNF mutations remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, we profile the expression levels of all 29 SWI\/SNF genes in 33 tumor types using DNA and mRNA data from The Cancer Genome Atlas, comprising approximately 11,000 samples. We find that\n                      <jats:italic>ACTL6B<\/jats:italic>\n                      ,\n                      <jats:italic>DPF1<\/jats:italic>\n                      ,\n                      <jats:italic>DPF3<\/jats:italic>\n                      and\n                      <jats:italic>SMARCD3<\/jats:italic>\n                      vary the most among tumor types and that 10 out of 33 tumor types show distinct SWI\/SNF gene expression signatures. The SWI\/SNF gene expression in tumors are partly influenced by their tissue of origin. Furthermore, the mean expression levels of SWI\/SNF subtype-specific genes are overall similar between tumor types, with higher variations in cBAF compared to PBAF and GBAF. Mutations in SWI\/SNF genes result in only minor changes in SWI\/SNF gene expression levels but are associated with downstream regulation of transcriptional programs linked to epigenetic regulation, especially in colon adenocarcinoma, kidney renal clear cell carcinoma, stomach adenocarcinoma and uterine corpus endometrial carcinoma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study provides insights into SWI\/SNF gene and subtype expression in cancer, which may contribute to the development of biomarkers and targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13072-026-00696-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:25:52Z","timestamp":1787243152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delineating SWI\/SNF gene and subtype expression in cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Vilma","family":"Canfjorden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"\u00d6sterlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"St\u00e5hlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"696_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"6","key":"696_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592\u2013601.","journal-title":"Nat Genet"},{"issue":"1","key":"696_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055119","volume":"8","author":"AH Shain","year":"2013","unstructured":"Shain AH, Pollack JR. The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS ONE. 2013;8(1):e55119.","journal-title":"PLoS ONE"},{"issue":"7","key":"696_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson BG, Roberts CWM. SWI\/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"696_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1021\/acs.biochem.5b01191","volume":"55","author":"C Kadoch","year":"2016","unstructured":"Kadoch C, Copeland RA, Keilhack H. PRC2 and SWI\/SNF chromatin remodeling complexes in health and disease. Biochemistry. 2016;55(11):1600\u201314.","journal-title":"Biochemistry"},{"issue":"4","key":"696_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, et al. Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell. 2010;18(4):316\u201328.","journal-title":"Cancer Cell"},{"key":"696_CR7","doi-asserted-by":"crossref","unstructured":"Bracken AP, Brien GL, Verrijzer CP. Dangerous liaisons: interplay between SWI\/SNF, NuRD, and Polycomb in chromatin regulation and cancer. Genes Dev. 2019;33(15-16):936-959.","DOI":"10.1101\/gad.326066.119"},{"issue":"5","key":"696_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/path.5042","volume":"244","author":"MJ McBride","year":"2018","unstructured":"McBride MJ, Kadoch C. Disruption of mammalian SWI\/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities. J Pathol. 2018;244(5):638\u201349.","journal-title":"J Pathol"},{"issue":"1","key":"696_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cell.2017.08.002","volume":"171","author":"B Schuettengruber","year":"2017","unstructured":"Schuettengruber B, Bourbon HM, Di Croce L, Cavalli G. Genome regulation by polycomb and trithorax: 70 years and counting. Cell. 2017;171(1):34\u201357.","journal-title":"Cell"},{"issue":"11","key":"696_CR10","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1074\/jbc.RA117.001065","volume":"293","author":"A Alpsoy","year":"2018","unstructured":"Alpsoy A, Dykhuizen EC. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI\/SNF chromatin remodeling subcomplexes. J Biol Chem. 2018;293(11):3892\u2013903.","journal-title":"J Biol Chem"},{"issue":"12","key":"696_CR11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","volume":"20","author":"BC Michel","year":"2018","unstructured":"Michel BC, D\u2019Avino AR, Cassel SH, Mashtalir N, McKenzie ZM, McBride MJ, et al. A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nat Cell Biol. 2018;20(12):1410\u201320.","journal-title":"Nat Cell Biol"},{"issue":"19","key":"696_CR12","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1002\/j.1460-2075.1996.tb00921.x","volume":"15","author":"W Wang","year":"1996","unstructured":"Wang W, C\u00f4t\u00e9 J, Xue Y, Zhou S, Khavari PA, Biggar SR, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 1996;15(19):5370\u201382.","journal-title":"EMBO J"},{"issue":"17","key":"696_CR13","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1101\/gad.10.17.2117","volume":"10","author":"W Wang","year":"1996","unstructured":"Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR. Diversity and specialization of mammalian SWI\/SNF complexes. Genes Dev. 1996;10(17):2117\u201330.","journal-title":"Genes Dev"},{"issue":"13","key":"696_CR14","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/1878-0261.13195","volume":"16","author":"M Lind\u00e9n","year":"2022","unstructured":"Lind\u00e9n M, Vannas C, \u00d6sterlund T, Andersson L, Osman A, Escobar M, et al. FET fusion oncoproteins interact with BRD4 and SWI\/SNF chromatin remodelling complex subtypes in sarcoma. Mol Oncol. 2022;16(13):2470\u201395.","journal-title":"Mol Oncol"},{"issue":"1","key":"696_CR15","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1038\/s41467-018-07528-9","volume":"9","author":"J Gatchalian","year":"2018","unstructured":"Gatchalian J, Malik S, Ho J, Lee DS, Kelso TWR, Shokhirev MN, et al. A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells. Nat Commun. 2018;9(1):5139.","journal-title":"Nat Commun"},{"key":"696_CR16","doi-asserted-by":"crossref","unstructured":"Nakayama RT, Pulice JL, Valencia AM, McBride MJ, McKenzie ZM, Gillespie MA, et al. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters. Nat Genet. 2017;49(11):1613-1623.","DOI":"10.1038\/ng.3958"},{"issue":"1","key":"696_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Wang S, Troisi EC, Howard TP, Haswell JR, Wolf BK, et al. BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors. Nat Commun. 2019;10(1):1881.","journal-title":"Nat Commun"},{"key":"696_CR18","doi-asserted-by":"crossref","unstructured":"Liao J, Ho J, Burns M, Dykhuizen EC, Hargreaves DC. Collaboration between distinct SWI\/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes. Immunity. 2024;57(8):1780-1795.e6.","DOI":"10.1016\/j.immuni.2024.05.008"},{"key":"696_CR19","doi-asserted-by":"crossref","unstructured":"Mittal P, Roberts CWM. The SWI\/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17(7):435-448.","DOI":"10.1038\/s41571-020-0357-3"},{"key":"696_CR20","doi-asserted-by":"publisher","first-page":"251686572211156","DOI":"10.1177\/25168657221115656","volume":"15","author":"CA Jones","year":"2022","unstructured":"Jones CA, Tansey WP, Weissmiller AM. Emerging themes in mechanisms of tumorigenesis by SWI\/SNF subunit mutation. Epigenet Insights. 2022;15:25168657221115656.","journal-title":"Epigenet Insights"},{"issue":"47","key":"696_CR21","doi-asserted-by":"publisher","first-page":"32254","DOI":"10.1074\/jbc.M806061200","volume":"283","author":"MD Kaeser","year":"2008","unstructured":"Kaeser MD, Aslanian A, Dong MQ, Yates JR 3rd, Emerson BM. BRD7, a novel PBAF-specific SWI\/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem. 2008;283(47):32254\u201363.","journal-title":"J Biol Chem"},{"key":"696_CR22","doi-asserted-by":"crossref","unstructured":"Hodges C, Kirkland JG, Crabtree GR. The many roles of BAF (mSWI\/SNF) and PBAF complexes in cancer. Cold Spring Harb Perspect Med. 2016;6(8):a026930.","DOI":"10.1101\/cshperspect.a026930"},{"issue":"13","key":"696_CR23","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1073\/pnas.0812889106","volume":"106","author":"L Ho","year":"2009","unstructured":"Ho L, Ronan JL, Wu J, Staahl BT, Chen L, Kuo A, et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A. 2009;106(13):5181\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"696_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2014.07.018","volume":"26","author":"KC Helming","year":"2014","unstructured":"Helming KC, Wang X, Roberts CWM. Vulnerabilities of mutant SWI\/SNF complexes in cancer. Cancer Cell. 2014;26(3):309\u201317.","journal-title":"Cancer Cell"},{"issue":"20","key":"696_CR25","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1158\/0008-5472.CAN-09-0733","volume":"69","author":"X Wang","year":"2009","unstructured":"Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, et al. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI\/SNF chromatin remodeling complex. Cancer Res. 2009;69(20):8094\u2013101.","journal-title":"Cancer Res"},{"issue":"6689","key":"696_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/28212","volume":"394","author":"I Versteege","year":"1998","unstructured":"Versteege I, S\u00e9venet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, et al. Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203\u20136.","journal-title":"Nature"},{"issue":"52","key":"696_CR27","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1038\/sj.onc.1203168","volume":"18","author":"MF DeCristofaro","year":"1999","unstructured":"DeCristofaro MF, Betz BL, Wang W, Weissman BE. Alteration of hSNF5\/INI1\/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms\u2019 tumors. Oncogene. 1999;18(52):7559\u201365.","journal-title":"Oncogene"},{"issue":"9","key":"696_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ajhg.2021.07.009","volume":"108","author":"LM Colli","year":"2021","unstructured":"Colli LM, Jessop L, Myers TA, Camp SY, Machiela MJ, Choi J, et al. Altered regulation of DPF3, a member of the SWI\/SNF complexes, underlies the 14q24 renal cancer susceptibility locus. Am J Hum Genet. 2021;108(9):1590\u2013610.","journal-title":"Am J Hum Genet"},{"issue":"49","key":"696_CR29","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","volume":"26","author":"S Glaros","year":"2007","unstructured":"Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene. 2007;26(49):7058\u201366.","journal-title":"Oncogene"},{"issue":"10","key":"696_CR30","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.18632\/oncotarget.1945","volume":"5","author":"B Kahali","year":"2014","unstructured":"Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, et al. The silencing of the SWI\/SNF subunit and anticancer gene BRM in rhabdoid tumors. Oncotarget. 2014;5(10):3316\u201332.","journal-title":"Oncotarget"},{"issue":"35","key":"696_CR31","doi-asserted-by":"publisher","first-page":"56153","DOI":"10.18632\/oncotarget.10593","volume":"7","author":"SB Marquez-Vilendrer","year":"2016","unstructured":"Marquez-Vilendrer SB, Thompson K, Lu L, Reisman D. Mechanism of BRG1 silencing in primary cancers. Oncotarget. 2016;7(35):56153\u201369.","journal-title":"Oncotarget"},{"key":"696_CR32","volume":"4","author":"SB Marquez","year":"2014","unstructured":"Marquez SB, Thompson KW, Lu L, Reisman D. Beyond mutations: additional mechanisms and implications of SWI\/SNF complex inactivation. Front Oncol. 2014;4:372.","journal-title":"Front Oncol"},{"issue":"24","key":"696_CR33","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1093\/emboj\/cdg621","volume":"22","author":"B Bourachot","year":"2003","unstructured":"Bourachot B, Yaniv M, Muchardt C. Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation. EMBO J. 2003;22(24):6505\u201315.","journal-title":"EMBO J"},{"key":"696_CR34","unstructured":"The cancer genome atlas program (TCGA) ccg. National Cancer Institute. Available from https:\/\/www.cancer.gov\/tcga"},{"issue":"10","key":"696_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"11","key":"696_CR36","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1111\/bph.70390","volume":"183","author":"\u00c1 Bartha","year":"2026","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot: an enhanced platform for pharmacological target identification through cross-stage and pan-cancer gene expression analysis. Br J Pharmacol. 2026;183(11):2648\u201359.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"696_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"key":"696_CR38","doi-asserted-by":"crossref","unstructured":"Saha D, Animireddy S, Bartholomew B. The SWI\/SNF ATP-dependent chromatin remodeling complex in cell lineage priming and early development. Biochem Soc Trans. 2024;52(2):603-616.","DOI":"10.1042\/BST20230416"},{"issue":"1","key":"696_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s42003-022-03490-x","volume":"5","author":"J Hern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Hern\u00e1ndez-Garc\u00eda J, Diego-Martin B, Kuo PH, Jami-Alahmadi Y, Vashisht AA, Wohlschlegel J, et al. Comprehensive identification of SWI\/SNF complex subunits underpins deep eukaryotic ancestry and reveals new plant components. Commun Biol. 2022;5(1):549.","journal-title":"Commun Biol"},{"key":"696_CR40","doi-asserted-by":"crossref","unstructured":"Reddy D, Bhattacharya S, Workman JL. (mis)-Targeting of SWI\/SNF complex(es) incancer. Cancer Metastasis Rev. 2023;42(2):455-470.","DOI":"10.1007\/s10555-023-10102-5"},{"issue":"7280","key":"696_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature08911","volume":"463","author":"L Ho","year":"2010","unstructured":"Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463(7280):474\u201384.","journal-title":"Nature"},{"issue":"2","key":"696_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2007.06.019","volume":"55","author":"J Lessard","year":"2007","unstructured":"Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron. 2007;55(2):201\u201315.","journal-title":"Neuron"},{"issue":"7013","key":"696_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature03071","volume":"432","author":"H Lickert","year":"2004","unstructured":"Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature. 2004;432(7013):107\u201312.","journal-title":"Nature"},{"key":"696_CR44","doi-asserted-by":"crossref","unstructured":"Ho PJ, Lloyd SM, Bao X. Unwinding chromatin at the right places: how BAF is targeted to specific genomic locations during development. Development. 2019;146(19):dev178780","DOI":"10.1242\/dev.178780"},{"issue":"17","key":"696_CR45","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1101\/gad.471408","volume":"22","author":"M Lange","year":"2008","unstructured":"Lange M, Kaynak B, Forster UB, T\u00f6njes M, Fischer JJ, Grimm C, et al. Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev. 2008;22(17):2370\u201384.","journal-title":"Genes Dev"},{"issue":"3","key":"696_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41556-023-01093-0","volume":"25","author":"H Zou","year":"2023","unstructured":"Zou H, Poore B, Brown EE, Qian J, Xie B, Asimakidou E, et al. A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis. Nat Cell Biol. 2023;25(3):493\u2013507.","journal-title":"Nat Cell Biol"},{"key":"696_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.critrevonc.2018.01.009","volume":"123","author":"S Savas","year":"2018","unstructured":"Savas S, Skardasi G. The SWI\/SNF complex subunit genes: their functions, variations, and links to risk and survival outcomes in human cancers. Crit Rev Oncol Hematol. 2018;123:114\u201331.","journal-title":"Crit Rev Oncol Hematol"},{"key":"696_CR48","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1499","volume":"3","author":"J Anaya","year":"2015","unstructured":"Anaya J, Reon B, Chen WM, Bekiranov S, Dutta A. A pan-cancer analysis of prognostic genes. PeerJ. 2015;3:e1499.","journal-title":"PeerJ"},{"issue":"5","key":"696_CR49","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","volume":"175","author":"N Mashtalir","year":"2018","unstructured":"Mashtalir N, D\u2019Avino AR, Michel BC, Luo J, Pan J, Otto JE, et al. Modular organization and assembly of SWI\/SNF family chromatin remodeling complexes. Cell. 2018;175(5):1272-88.e20.","journal-title":"Cell"},{"issue":"3","key":"696_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41416-019-0615-2","volume":"122","author":"P Chammas","year":"2020","unstructured":"Chammas P, Mocavini I, Di Croce L. Engaging chromatin: PRC2 structure meets function. Br J Cancer. 2020;122(3):315\u201328.","journal-title":"Br J Cancer"},{"issue":"7","key":"696_CR51","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/aps.2017.7","volume":"38","author":"Y Shi","year":"2017","unstructured":"Shi Y, Wang X-x, Zhuang Y-w, Jiang Y, Melcher K, Xu HE. Structure of the PRC2 complex and application to drug discovery. Acta Pharmacol Sin. 2017;38(7):963\u201376.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"696_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.molcel.2004.08.028","volume":"15","author":"K Sabapathy","year":"2004","unstructured":"Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell. 2004;15(5):713\u201325.","journal-title":"Mol Cell"},{"key":"696_CR53","doi-asserted-by":"crossref","unstructured":"Chabanon RM, Morel D, Postel-Vinay S. Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI\/SNF-defective cancers. Semin Cancer Biol. 2019;61:180-198.","DOI":"10.1016\/j.semcancer.2019.09.018"},{"key":"696_CR54","doi-asserted-by":"crossref","unstructured":"Schick S, Rendeiro AF, Runggatscher K, Ringler A, Boidol B, Hinkel M, et al. Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers. Nat Genet. 2019;51(9):1399-1410.","DOI":"10.1038\/s41588-019-0477-9"},{"key":"696_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1101\/sqb.2016.81.031021","volume":"81","author":"JL Pulice","year":"2016","unstructured":"Pulice JL, Kadoch C. Composition and function of mammalian SWI\/SNF chromatin remodeling complexes in human disease. Cold Spring Harb Symp Quant Biol. 2016;81:53\u201360.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"3","key":"696_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgad011","volume":"44","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Zhao J, Wu Y, Zhang N, Shen W. ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis. 2023;44(3):197\u2013208.","journal-title":"Carcinogenesis"},{"issue":"2","key":"696_CR57","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49(2):296\u2013302.","journal-title":"Nat Genet"},{"issue":"12","key":"696_CR58","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","volume":"20","author":"K Mardinian","year":"2021","unstructured":"Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R. SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy. Mol Cancer Ther. 2021;20(12):2341\u201351.","journal-title":"Mol Cancer Ther"},{"key":"696_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep04147","volume":"4","author":"R Zhong","year":"2014","unstructured":"Zhong R, Liu L, Tian Y, Wang Y, Tian J, Zhu BB, et al. Genetic variant in SWI\/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis. Sci Rep. 2014;4:4147.","journal-title":"Sci Rep"},{"issue":"1","key":"696_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/liv.12005","volume":"33","author":"M Endo","year":"2013","unstructured":"Endo M, Yasui K, Zen Y, Gen Y, Zen K, Tsuji K, et al. Alterations of the SWI\/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. Liver Int. 2013;33(1):105\u201317.","journal-title":"Liver Int"},{"issue":"1","key":"696_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-024-02015-w","volume":"23","author":"K Zhuang","year":"2024","unstructured":"Zhuang K, Wang L, Lu C, Liu Z, Yang D, Zhong H, et al. Assessment of SWI\/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancer. Mol Cancer. 2024;23(1):176.","journal-title":"Mol Cancer"},{"issue":"16","key":"696_CR62","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.yexcr.2012.06.011","volume":"318","author":"A Kothandapani","year":"2012","unstructured":"Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick SM. Downregulation of SWI\/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp Cell Res. 2012;318(16):1973\u201386.","journal-title":"Exp Cell Res"},{"issue":"2","key":"696_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ng.3734","volume":"49","author":"C Kadoch","year":"2017","unstructured":"Kadoch C, Williams RT, Calarco JP, Miller EL, Weber CM, Braun SMG, et al. Dynamics of BAF-polycomb complex opposition on heterochromatin in normal and oncogenic states. Nat Genet. 2017;49(2):213\u201322.","journal-title":"Nat Genet"},{"issue":"12","key":"696_CR64","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/nm.3968","volume":"21","author":"KH Kim","year":"2015","unstructured":"Kim KH, Kim W, Howard TP, Vazquez F, Tsherniak A, Wu JN, et al. SWI\/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat Med. 2015;21(12):1491\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"696_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nm.3480","volume":"20","author":"KC Helming","year":"2014","unstructured":"Helming KC, Wang X, Wilson BG, Vazquez F, Haswell JR, Manchester HE, et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med. 2014;20(3):251\u20134.","journal-title":"Nat Med"},{"issue":"6","key":"696_CR66","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1128\/MCB.01372-13","volume":"34","author":"BG Wilson","year":"2014","unstructured":"Wilson BG, Helming KC, Wang X, Kim Y, Vazquez F, Jagani Z, et al. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. Mol Cell Biol. 2014;34(6):1136\u201344.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"696_CR67","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1073\/pnas.1316793111","volume":"111","author":"GR Hoffman","year":"2014","unstructured":"Hoffman GR, Rahal R, Buxton F, Xiang K, McAllister G, Frias E, et al. Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc Natl Acad Sci U S A. 2014;111(8):3128\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"696_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00868-4","volume":"13","author":"A Italiano","year":"2020","unstructured":"Italiano A. Targeting epigenetics in sarcomas through EZH2 inhibition. J Hematol Oncol. 2020;13(1):33.","journal-title":"J Hematol Oncol"},{"issue":"19","key":"696_CR69","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.1303800110","volume":"110","author":"SK Knutson","year":"2013","unstructured":"Knutson SK, Warholic NM, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci U S A. 2013;110(19):7922\u20137.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13072-026-00696-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-026-00696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-026-00696-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:02:22Z","timestamp":1787342542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13072-026-00696-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1186\/s13072-026-00696-9","relation":{},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS declares stock ownership in Iscaff Pharma, SiMSen Diagnostics and Tulebovaasta. AS is a board member in Tulebovaasta. The remaining authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"35"}}